Professor Jean-Pierre Kinet is Manager in the division of Allergy and Immunology and professor of pathology at Beth Israel Deaconess Medical Center and at Harvard Medical School. Professor Kinet is the author of more than 190 publications. He is well known for his discovery about gene and protein characterization which encode the IgE receiver/receptor of high-affinity, a key to cause allergic reactions. He is a member of the American Foundation of Asthma and foreign member elected from the Royal Academy of Medicine in Belgium. Doctor Kinet is also a member of the scientific board of UCB Pharma and of several biotech companies.
He is co-founder of AB Sciences and president of iXLife, a private investment funds which is dealing with 4 biotech companies.